Effectiveness of mRESVIA Against Serious Endpoints related to RSV in Kaiser Permanente Northern California (ERASE-RSV)

First published 26/03/2026

Last updated 26/03/2026

EU PAS number:

EUPAS1000000946

Study

Ongoing

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

​​Effectiveness of mRESVIA Against Serious Endpoints related to RSV in Kaiser Permanente Northern California (ERASE-RSV)​

Secondary tabs

Share this page

Effectiveness of mRESVIA Against Serious Endpoints related to RSV in Kaiser Permanente Northern California (ERASE-RSV)